Good Steward Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
9,640
+46
+0.5% +$1.2K 0.14% 66
2026
Q1
$269K Sell
9,594
-2
-0% -$53 0.17% 52
2025
Q4
$239K Sell
9,596
-1,982
-17% -$50K 0.16% 61
2025
Q3
$295K Sell
11,578
-3,851
-25% -$95K 0.2% 57
2025
Q2
$374K Sell
15,429
-7,086
-31% -$165K 0.29% 57
2025
Q1
$571K Buy
+22,515
New +$589K 0.52% 51

Other funds holding PFE

Good Steward Wealth Advisors's PFE Position: Q2 2026 in Review

Good Steward Wealth Advisors increased its Pfizer (PFE) stake by 0.48% in Q2 2026, buying an estimated $1.2K and bringing the position to 9,640 shares worth $232K. The position accounts for 0.14% of the portfolio, ranked #66.

Good Steward Wealth Advisors first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $571K in Q1 2025. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Good Steward Wealth Advisors held 9,640 shares of Pfizer worth $232K as of Q2 2026.
  • Good Steward Wealth Advisors bought 46 Pfizer shares in Q2 2026, an estimated $1.2K.
  • Pfizer made up 0.14% of Good Steward Wealth Advisors's portfolio in Q2 2026, its #66 holding.
  • Good Steward Wealth Advisors first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Good Steward Wealth Advisors's Pfizer position peaked at $571K in Q1 2025.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.